Teva found responsible for opioid addiction in New York

The opioid analgesic Oxycodone


Photo:

eric baradat / Agence France-Presse / Getty Images

A jury in the state of New York has found that Teva Pharmaceuticals Industries Ltd.

was responsible for playing a role in promoting opioid dependence.

The verdict followed a lawsuit in the state Supreme Court on Long Island. New York Justice Minister Letitia James had sued Teva and other pharmaceutical companies, claiming they were responsible for producing addictive painkillers that have caused a public health crisis.

“Today, we took a significant step in redressing the injustices that this country has collectively experienced over the last two decades,” she said. James.

“Teva Pharmaceuticals strongly disagrees with today’s result and will prepare for a speedy appeal,” a spokeswoman for the company said. She added that the company is requesting that a judge declare a lawsuit because New York lawyers, according to Teva, misrepresented the amount of opioids sold.

US-traded stocks in Teva, an Israel-based company specializing in generic versions of prescription drugs, fell about 4% Thursday afternoon.

Addiction experts agree on the most effective way to help opioid addicts: Medication-assisted treatment. However, most inpatient rehabilitation facilities in the United States do not offer this option. WSJ’s Jason Bellini reports on why the drug option is controversial and in many places difficult to find. Photo: Ryno Eksteen and Thomas Williams (Video from 16.11.17)

Read more articles on the substance abuse crisis, selected by the WSJ editors

Write to Matt Grossman at matt.grossman@wsj.com

Copyright © 2021 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

.

Leave a Comment